| Trial ID: | L5929 |
| Source ID: | NCT01219582
|
| Associated Drug: |
Glucobay M (Acarbose/Metformin, Bay81-9783)
|
| Title: |
GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients
|
| Acronym: |
GLOBE
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Glucobay M (Acarbose/Metformin, BAY81-9783)
|
| Outcome Measures: |
Primary: Change in fasting blood glucose levels, 12 weeks|Change in post-prandial glucose values, 12 weeks|Change in Hemoglobin A1c (HbA1c) levels, 12 weeks | Secondary: Number of patient with adverse events, 12 weeks|Percentage of patients with satisfaction of treatment, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Bayer
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
9364
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2010-10
|
| Completion Date: |
2012-12
|
| Results First Posted: |
|
| Last Update Posted: |
2013-11-13
|
| Locations: |
Many Locations, India
|
| URL: |
https://clinicaltrials.gov/show/NCT01219582
|
